Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study by Kawai, Akira, Dr, Araki, Nobuhito, MD, Sugiura, Hideshi, MD, Ueda, Takafumi, MD, Yonemoto, Tsukasa, PhD, Takahashi, Mitsuru, PhD, Morioka, Hideo, MD, Hiraga, Hiroaki, MD, Hiruma, Toru, PhD, Kunisada, Toshiyuki, MD, Matsumine, Akihiko, MD, Tanase, Takanori, MSc, Hasegawa, Tadashi, MD, Takahashi, Shunji, MD

Get full text

TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial by Yoshino, Takayuki, Dr, Mizunuma, Nobuyuki, MD, Yamazaki, Kentaro, MD, Nishina, Tomohiro, MD, Komatsu, Yoshito, MD, Baba, Hideo, Prof, Tsuji, Akihito, MD, Yamaguchi, Kensei, MD, Muro, Kei, MD, Sugimoto, Naotoshi, MD, Tsuji, Yasushi, MD, Moriwaki, Toshikazu, MD, Esaki, Taito, MD, Hamada, Chikuma, Prof, Tanase, Takanori, MSc, Ohtsu, Atsushi, MD

Get full text